X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
oncology (34) 34
clinical neurology (30) 30
index medicus (27) 27
male (25) 25
adult (24) 24
female (24) 24
middle aged (24) 24
chemotherapy (18) 18
aged (17) 17
brain neoplasms - drug therapy (17) 17
medicine & public health (17) 17
neurology (16) 16
radiotherapy (16) 16
treatment outcome (14) 14
neurosciences (13) 13
brain neoplasms - mortality (12) 12
oligodendroglioma (12) 12
survival rate (12) 12
radiation (11) 11
temozolomide (11) 11
adults (10) 10
brain neoplasms - pathology (10) 10
brain neoplasms - therapy (10) 10
cancer research (10) 10
glioblastoma (10) 10
tumors (10) 10
bevacizumab (9) 9
brain neoplasms - diagnosis (9) 9
brain neoplasms - secondary (9) 9
brain tumors (9) 9
clinical investigations (9) 9
evidence-based medicine (9) 9
glioblastoma - drug therapy (9) 9
medical colleges (9) 9
metastasis (9) 9
practice guidelines (9) 9
public health (9) 9
systematic review (9) 9
care and treatment (8) 8
invited manuscript (8) 8
practice guideline (8) 8
young adult (8) 8
adolescent (7) 7
brain metastases (7) 7
brain neoplasms - genetics (7) 7
brain neoplasms - radiotherapy (7) 7
cancer (7) 7
combined modality therapy (7) 7
follow-up studies (7) 7
gliomas (7) 7
magnetic resonance imaging (7) 7
oligodendroglioma - therapy (7) 7
anaplastic oligodendroglioma (6) 6
angiogenesis inhibitors - therapeutic use (6) 6
antibodies, monoclonal - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
lomustine - administration & dosage (6) 6
malignant glioma (6) 6
oligodendroglioma - drug therapy (6) 6
phase-ii trial (6) 6
practice guidelines as topic (6) 6
procarbazine - administration & dosage (6) 6
retrospective studies (6) 6
surgery (6) 6
survival (6) 6
therapy (6) 6
trial (6) 6
vincristine - administration & dosage (6) 6
aged, 80 and over (5) 5
cell lung-cancer (5) 5
dacarbazine - analogs & derivatives (5) 5
disease-free survival (5) 5
neoplasm recurrence, local - drug therapy (5) 5
oligodendroglioma - genetics (5) 5
oligodendroglioma - mortality (5) 5
procarbazine (5) 5
prognosis (5) 5
radiation-therapy (5) 5
surgical resection (5) 5
anaplastic (4) 4
animals (4) 4
antibodies, monoclonal, humanized (4) 4
antineoplastic agents - therapeutic use (4) 4
brain-tumors (4) 4
cerebral metastases (4) 4
disease progression (4) 4
european organization (4) 4
glioblastoma - mortality (4) 4
glioblastoma - pathology (4) 4
glioblastoma multiforme (4) 4
glioma (4) 4
hematopoietic stem cell transplantation (4) 4
irradiation (4) 4
kaplan-meier estimate (4) 4
neoplasm recurrence, local - pathology (4) 4
oligoastrocytomas (4) 4
oligodendroglioma - pathology (4) 4
pcv (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 1/2010, Volume 96, Issue 1, pp. 45 - 68
Journal Article
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 1/2010, Volume 96, Issue 1, pp. 17 - 32
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 7/2012, Volume 108, Issue 3, pp. 491 - 498
Journal Article
Journal Article
by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Temozolomide | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis
Journal Article
Neuro-Oncology, ISSN 1522-8517, 6/2011, Volume 13, Issue 6, pp. 649 - 659
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2003, Volume 21, Issue 22, pp. 4151 - 4156
Journal Article